Royal Bank of Canada’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $150K | Buy |
41,263
+26,931
| +188% | +$97.9K | ﹤0.01% | 5017 |
|
2025
Q1 | $28K | Sell |
14,332
-14,668
| -51% | -$28.7K | ﹤0.01% | 5414 |
|
2024
Q4 | $55K | Buy |
29,000
+8,179
| +39% | +$15.5K | ﹤0.01% | 5154 |
|
2024
Q3 | $27K | Buy |
20,821
+755
| +4% | +$979 | ﹤0.01% | 5523 |
|
2024
Q2 | $21K | Buy |
20,066
+19,828
| +8,331% | +$20.8K | ﹤0.01% | 5653 |
|
2024
Q1 | $0 | Buy |
238
+138
| +138% | – | ﹤0.01% | 6503 |
|
2023
Q4 | $0 | Buy |
+100
| New | – | ﹤0.01% | 6520 |
|
2023
Q3 | – | Sell |
-500
| Closed | – | – | 6531 |
|
2023
Q2 | $0 | Buy |
+500
| New | – | ﹤0.01% | 6740 |
|
2022
Q4 | – | Sell |
-467
| Closed | – | – | 6699 |
|
2022
Q3 | $0 | Sell |
467
-120
| -20% | – | ﹤0.01% | 6907 |
|
2022
Q2 | $0 | Sell |
587
-10,250
| -95% | – | ﹤0.01% | 6856 |
|
2022
Q1 | $8K | Sell |
10,837
-24,958
| -70% | -$18.4K | ﹤0.01% | 6548 |
|
2021
Q4 | $80K | Buy |
35,795
+20,584
| +135% | +$46K | ﹤0.01% | 5557 |
|
2021
Q3 | $44K | Buy |
15,211
+3,219
| +27% | +$9.31K | ﹤0.01% | 5712 |
|
2021
Q2 | $45K | Sell |
11,992
-1,951
| -14% | -$7.32K | ﹤0.01% | 5610 |
|
2021
Q1 | $48K | Sell |
13,943
-60,745
| -81% | -$209K | ﹤0.01% | 5415 |
|
2020
Q4 | $209K | Buy |
74,688
+68,394
| +1,087% | +$191K | ﹤0.01% | 4300 |
|
2020
Q3 | $16K | Buy |
6,294
+4,756
| +309% | +$12.1K | ﹤0.01% | 5280 |
|
2020
Q2 | $21K | Sell |
1,538
-276
| -15% | -$3.77K | ﹤0.01% | 5092 |
|
2020
Q1 | $14K | Sell |
1,814
-6,493
| -78% | -$50.1K | ﹤0.01% | 5189 |
|
2019
Q4 | $52K | Buy |
8,307
+6,997
| +534% | +$43.8K | ﹤0.01% | 4841 |
|
2019
Q3 | $5K | Sell |
1,310
-866
| -40% | -$3.31K | ﹤0.01% | 5366 |
|
2019
Q2 | $10K | Buy |
2,176
+610
| +39% | +$2.8K | ﹤0.01% | 5171 |
|
2019
Q1 | $12K | Hold |
1,566
| – | – | ﹤0.01% | 5044 |
|
2018
Q4 | $8K | Sell |
1,566
-321
| -17% | -$1.64K | ﹤0.01% | 5170 |
|
2018
Q3 | $17K | Buy |
1,887
+1,027
| +119% | +$9.25K | ﹤0.01% | 5146 |
|
2018
Q2 | $9K | Buy |
860
+742
| +629% | +$7.77K | ﹤0.01% | 5264 |
|
2018
Q1 | $2K | Sell |
118
-450
| -79% | -$7.63K | ﹤0.01% | 5483 |
|
2017
Q4 | $9K | Sell |
568
-4,084
| -88% | -$64.7K | ﹤0.01% | 5140 |
|
2017
Q3 | $92K | Buy |
4,652
+3,878
| +501% | +$76.7K | ﹤0.01% | 4345 |
|
2017
Q2 | $10K | Sell |
774
-1,557
| -67% | -$20.1K | ﹤0.01% | 5037 |
|
2017
Q1 | $21K | Sell |
2,331
-11,058
| -83% | -$99.6K | ﹤0.01% | 4914 |
|
2016
Q4 | $140K | Buy |
13,389
+589
| +5% | +$6.16K | ﹤0.01% | 3965 |
|
2016
Q3 | $116K | Hold |
12,800
| – | – | ﹤0.01% | 4015 |
|
2016
Q2 | $96K | Buy |
12,800
+9,144
| +250% | +$68.6K | ﹤0.01% | 4124 |
|
2016
Q1 | $33K | Sell |
3,656
-16,330
| -82% | -$147K | ﹤0.01% | 4609 |
|
2015
Q4 | $258K | Buy |
19,986
+7,608
| +61% | +$98.2K | ﹤0.01% | 3663 |
|
2015
Q3 | $119K | Sell |
12,378
-12,880
| -51% | -$124K | ﹤0.01% | 4098 |
|
2015
Q2 | $260K | Buy |
25,258
+4,246
| +20% | +$43.7K | ﹤0.01% | 3695 |
|
2015
Q1 | $234K | Buy |
21,012
+18,912
| +901% | +$211K | ﹤0.01% | 3678 |
|
2014
Q4 | $24K | Buy |
2,100
+850
| +68% | +$9.71K | ﹤0.01% | 4760 |
|
2014
Q3 | $28K | Sell |
1,250
-19,700
| -94% | -$441K | ﹤0.01% | 4626 |
|
2014
Q2 | $582K | Buy |
+20,950
| New | +$582K | ﹤0.01% | 2836 |
|